Home›Stock Screener›Indoco Remedies›Quarterly Results

Indoco Remedies Quarterly Results

Latest Quarter Net Profit
₹20 Cr
QSept 2026
Quarterly Results

Indoco Remedies quarterly results. In Sept 2026, Indoco Remedies (INDOCO) reported revenue ₹546 Cr and net profit ₹20 Cr — revenue +15.4% YoY. View INDOCO annual price range for the annual high/low range and current price position.

INDOCO Quarterly Results — Revenue, Profit & EPS Highlights

Indoco Remedies latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore INDOCO share price charts to track price trends across different timeframes.

  • Revenue of ₹546 Cr in Sept 2026 (+18.7% vs Mar 2026, +15.4% vs Sept 2025)
  • Net Profit of ₹20 Cr in Sept 2026 (+183.3% vs Mar 2026, +322.2% vs Sept 2025)
  • EBITDA of ₹72 Cr in Sept 2026 (+111.8% vs Mar 2026)
  • Operating Margin of 7.0% in Sept 2026 (+0.0pp vs Mar 2026)
  • Earnings Per Share of ₹2.11 in Sept 2026 (+182.1% vs Mar 2026)

Indoco Remedies Quarterly Results — Revenue, EBITDA, Net Profit & EPS

INDOCO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 546 460 566 473 386 18.7% 15.4%
Net Profit (₹ Cr) 20 -24 65 -9 -41 - -
EBITDA (₹ Cr) 72 34 139 30 -5 - -
EPS (₹) 2.11 -2.57 7.09 -1.00 -4.48 - -
Operating Margin (%) 7.0% 7.0% 9.0% 6.0% -2.0% - -

INDOCO Share Price Trend — 1-Year Movement Across Quarterly Results

Indoco Remedies 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit INDOCO screener.

Profitability Ratios

Profit Margin 3.7%
EBITDA Margin 13.2%
Operating Margin 7.0%
ROE (Annual) 8.6%

Balance Sheet Highlights

Total Assets ₹2,593 Cr
Total Equity ₹932 Cr
Current Assets ₹ Cr
Current Liabilities ₹609 Cr

Cash Flow Analysis

Operating Cash Flow ₹192 Cr
Investing Cash Flow ₹-102 Cr
Financing Cash Flow ₹-77 Cr
Net Cash Flow ₹14 Cr

Current Market Data

Current Price ₹233.08
Exchange NSE
Last Updated Nov 19, 2026

INDOCO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Indoco Remedies latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores